CrystalGenomics Inc Cash Flow-to-Debt Ratio
CrystalGenomics Inc cash flow-to-debt ratio. CrystalGenomics Inc (083790) has a Cash Flow-to-Debt Ratio of -0.09x as of September 2025, meaning its operating cash flow of ₩-11.39 Billion could theoretically repay 0% of its total liabilities (₩124.24 Billion) in one year. Check CrystalGenomics Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of CrystalGenomics Inc (2014–2024)
Cash flow-to-debt ratio of CrystalGenomics Inc from 2014 to 2024. Historical debt coverage capacity for CrystalGenomics Inc across 11 annual periods. Check total reinvestment intensity of CrystalGenomics Inc to assess the company's total reinvestment commitment from operating cash flow.
CrystalGenomics Inc Cash Flow-to-Debt Ratio by Year (2014–2024)
CrystalGenomics Inc cash flow-to-debt ratio by year from 2014 to 2024. Year-by-year debt coverage analysis for CrystalGenomics Inc. For the full cash flow conversion analysis, see how efficiently does CrystalGenomics Inc generate cash.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.16x | ₩-25.85 Billion | ₩161.95 Billion | ▲ +51.8% |
| 2023 | -0.33x | ₩-32.41 Billion | ₩97.82 Billion | ▼ -82.4% |
| 2022 | -0.18x | ₩-24.40 Billion | ₩134.34 Billion | ▼ -98.3% |
| 2021 | -0.09x | ₩-11.46 Billion | ₩125.09 Billion | ▲ +42.9% |
| 2020 | -0.16x | ₩-16.38 Billion | ₩102.20 Billion | ▼ -416.9% |
| 2019 | -0.03x | ₩-7.14 Billion | ₩230.14 Billion | ▼ -86.2% |
| 2018 | -0.02x | ₩-1.21 Billion | ₩72.45 Billion | ▼ -128.4% |
| 2017 | 0.06x | ₩1.63 Billion | ₩27.88 Billion | ▲ +132.1% |
| 2016 | -0.18x | ₩-8.30 Billion | ₩45.51 Billion | ▼ -113.6% |
| 2015 | -0.09x | ₩-4.73 Billion | ₩55.34 Billion | ▼ -16.1% |
| 2014 | -0.07x | ₩-3.75 Billion | ₩51.02 Billion | — |